Lucie Guo

Feb 27, 2024 | retina-specialist.com | Lucie Guo |Theodore Leng

Take-home pointsAnti-VEGF medications have been highly effective in clinical trials for improving vision in diabetic macular edema. In real-world settings, patients receive injections less frequently than in clinical trials. Real-world studies have reported smaller gains in vision than clinical trials. Real-world data highlight racial and socioeconomic disparities in the usage and outcome of anti-VEGF therapy.